Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 - ResearchAndMarkets.com

Research and Markets
Posted on: 16 Mar 18

The "Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018" report has been added to ResearchAndMarkets.com's offering.

The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies.

The report provides a detailed understanding and analysis of how and why companies enter business, royalty financing agreements. The focus of the report is on partnerships for royalty assets where partners have entered an agreement to dispose of or acquire said assets. The report provides access to royalty financing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Royalty assets - where a specialist investment company acquires the rights to future royalty payments in return for payment of a lump sum payment to the licensor for the product

Revenue assets - also known as synthetic royalties', where a specialist investment company acquires the rights to a proportion of future revenue streams in return for a lump sum payment to the company

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report provides comprehensive access to royalty and revenue financing deals as announced in the life sciences industry since 2010.

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in royalty financing dealmaking

Chapter 3 - Overview of royalty financing structure

Chapter 4 - Leading royalty financing deals

Chapter 5 - Top 10 most active royalty financing dealmakers

Chapter 6 - Royalty financing contract documents 2010- 2018

Chapter 7 - Royalty financing agreement directory 2010- 2018

For more information about this report visit https://www.researchandmarkets.com/research/5b6xmt/global_royalty?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180316005292/en/

Business Wire
www.businesswire.com

Last updated on: 16/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.